Tc-99m Glucoheptonate Single Photon Emission Computed Tomography-Computed Tomography for Detection of Recurrent Glioma: A Prospective Comparison with N-13 Ammonia Positron Emission Tomography-Computed Tomography.
Ammonia
glioma recurrence
glucoheptonate
positron emission tomography-computed tomography
radiation necrosis
single photon emission computed tomography-computed tomography
Journal
Indian journal of nuclear medicine : IJNM : the official journal of the Society of Nuclear Medicine, India
ISSN: 0972-3919
Titre abrégé: Indian J Nucl Med
Pays: India
ID NLM: 8901274
Informations de publication
Date de publication:
Historique:
entrez:
2
5
2019
pubmed:
2
5
2019
medline:
2
5
2019
Statut:
ppublish
Résumé
To assess the efficacies of Tc-99m glucoheptonate single photon emission computed tomography-computed tomography (Tc-99m GHA SPECT-CT) and N-13 ammonia positron emission tomography-computed tomography (N-13 NH Fifty-five consecutive, histologically proven, and previously treated glioma patients (age, 38.9 ± 12.2 years; 61.8% males) presenting with clinical suspicion of recurrence were evaluated with Tc-99m GHA SPECT-CT and N-13 NH Based on the reference standard, 28/55 (50.9%) patients had recurrence. Sensitivity, specificity, positive predictive value, negative predictive value, accuracy of Tc-99m GHA SPECT-CT, and N-13 NH Tc-99m GHA SPECT-CT is an alternative imaging modality equally efficacious as N-13 NH
Identifiants
pubmed: 31040521
doi: 10.4103/ijnm.IJNM_164_18
pii: IJNM-34-107
pmc: PMC6481207
doi:
Types de publication
Journal Article
Langues
eng
Pagination
107-117Déclaration de conflit d'intérêts
There are no conflicts of interest.
Références
J Postgrad Med. 2004 Apr-Jun;50(2):89-93
pubmed: 15235200
Australas Radiol. 2004 Sep;48(3):296-301
pubmed: 15344976
J Clin Neurosci. 2005 Jan;12(1):27-31
pubmed: 16568553
J Neurooncol. 2006 Jun;78(2):145-51
pubmed: 16739028
J Neurooncol. 2007 May;82(3):305-11
pubmed: 17120157
AJR Am J Roentgenol. 2007 Jan;188(1):204-12
pubmed: 17179366
J Nucl Med. 2007 Sep;48(9):1468-81
pubmed: 17704239
Cancer J. 2007 Nov-Dec;13(6):349-54
pubmed: 18032970
Lancet Oncol. 2008 May;9(5):453-61
pubmed: 18452856
N Engl J Med. 2008 Jul 31;359(5):492-507
pubmed: 18669428
Nucl Med Commun. 2008 Aug;29(8):730-5
pubmed: 18753827
Nucl Med Commun. 2008 Dec;29(12):1052-8
pubmed: 18987525
J Neurooncol. 2009 Oct;95(1):1-11
pubmed: 19381441
Neuropathol Appl Neurobiol. 1990 Jun;16(3):205-11
pubmed: 1976235
Hell J Nucl Med. 2009 Sep-Dec;12(3):248-50
pubmed: 19936337
Nucl Med Commun. 2011 Mar;32(3):206-11
pubmed: 21224746
J Neurooncol. 2011 Oct;105(1):103-7
pubmed: 21503829
Clin Nucl Med. 2011 Aug;36(8):650-5
pubmed: 21716014
Neuro Oncol. 2011 Aug;13(8):806-19
pubmed: 21757446
J Nucl Med. 2011 Oct;52(10):1585-600
pubmed: 21840931
Lancet. 2012 May 26;379(9830):1984-96
pubmed: 22510398
Zhonghua Bing Li Xue Za Zhi. 2012 Apr;41(4):224-8
pubmed: 22800516
Indian J Nucl Med. 2011 Oct;26(4):165-70
pubmed: 23559709
Clin Nucl Med. 2014 Feb;39(2):e121-8
pubmed: 23579970
Clin Nucl Med. 2013 Jul;38(7):522-6
pubmed: 23698463
Nucl Med Commun. 2013 Nov;34(11):1046-54
pubmed: 24025920
Eur J Cancer. 2014 Sep;50(13):2309-18
pubmed: 24972545
Neuroradiology. 2014 Oct;56(10):893-902
pubmed: 24989883
CNS Oncol. 2014 Mar;3(2):123-36
pubmed: 25055018
Adv Drug Deliv Rev. 2014 Sep 30;76:98-115
pubmed: 25078721
Indian J Nucl Med. 2015 Jan-Mar;30(1):1-8
pubmed: 25589798
Mol Imaging. 2016 Apr 26;15:
pubmed: 27118759
J Neurochem. 1987 Aug;49(2):603-9
pubmed: 2885398
Semin Oncol. 1986 Mar;13(1):16-26
pubmed: 3006257
Prog Exp Tumor Res. 1985;29:210-8
pubmed: 4070632
J Nucl Med. 1977 Oct;18(10):957-61
pubmed: 903478